Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Julius

Showing results (21-30 of 82) with videos related to

Pageof 9
Sort By:
Deutsche Medizinische Wochenschrift (1946)|March 29, 2023
[State of the art: lipoprotein apheresis]Ulrike Schatz, Volker J J Schettler, Ulrich Julius
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|August 9, 2022
COVID-19 and Therapeutic ApheresisSergey Tselmin, Ulrich Julius, Natalia Jarzebska, et al.
Atherosclerosis. Supplements|November 4, 2017
Low rate of infectious complications following immunoadsorption therapy without regular substitution of intravenous immunoglobulinsSergey Tselmin, Ulrich Julius, Stefan R Bornstein, et al.
Atherosclerosis. Supplements|November 4, 2017
How effectively will PCSK9 inhibitors allow retrieval of freedom from apheresis in cardiovascular high risk patients? - Estimates form a large single centerBernd Hohenstein, Sergey Tselmin, Stefan R Bornstein, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|September 2, 2022
Correction: COVID-19 and Therapeutic ApheresisSergey Tselmin, Ulrich Julius, Natalia Jarzebska, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|April 5, 2013
Why an apheresis center should offer more than one lipoprotein apheresis methodUlrich Julius, Sabine Fischer, Ulrike Schatz, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 29, 2008
Successful therapy of pemphigus vulgaris with immunoadsorption using the TheraSorb adsorberClaudia Günther, Jörg Laske, Antje Frind, et al.
Atherosclerosis. Supplements|December 11, 2019
Experience with proprotein convertase subtilisin/kexine type 9 inhibitors (PCSK9i) in patients undergoing lipoprotein apheresisSergey Tselmin, Ulrich Julius, Nadine Weinert, et al.
Free Radical Biology & Medicine|February 28, 2012
Triglyceride, nonesterified fatty acids, and prediabetic neuropathy: role for oxidative-nitrosative stressSergey Lupachyk, Pierre Watcho, Nailia Hasanova, et al.
Atherosclerosis. Supplements|February 5, 2010
The Dresden Apheresis Center - experience with LDL apheresis and immunoadsorptionUlrich Julius, Sergey Tselmin, Sabine Fischer, et al.
Pageof 9

Showing results (21-30 of 82) with videos related to

Sort By:
Pageof 9
Deutsche Medizinische Wochenschrift (1946)|March 29, 2023
[State of the art: lipoprotein apheresis]Ulrike Schatz, Volker J J Schettler, Ulrich Julius
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|August 9, 2022
COVID-19 and Therapeutic ApheresisSergey Tselmin, Ulrich Julius, Natalia Jarzebska, et al.
Atherosclerosis. Supplements|November 4, 2017
Low rate of infectious complications following immunoadsorption therapy without regular substitution of intravenous immunoglobulinsSergey Tselmin, Ulrich Julius, Stefan R Bornstein, et al.
Atherosclerosis. Supplements|November 4, 2017
How effectively will PCSK9 inhibitors allow retrieval of freedom from apheresis in cardiovascular high risk patients? - Estimates form a large single centerBernd Hohenstein, Sergey Tselmin, Stefan R Bornstein, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|September 2, 2022
Correction: COVID-19 and Therapeutic ApheresisSergey Tselmin, Ulrich Julius, Natalia Jarzebska, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|April 5, 2013
Why an apheresis center should offer more than one lipoprotein apheresis methodUlrich Julius, Sabine Fischer, Ulrike Schatz, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 29, 2008
Successful therapy of pemphigus vulgaris with immunoadsorption using the TheraSorb adsorberClaudia Günther, Jörg Laske, Antje Frind, et al.
Atherosclerosis. Supplements|December 11, 2019
Experience with proprotein convertase subtilisin/kexine type 9 inhibitors (PCSK9i) in patients undergoing lipoprotein apheresisSergey Tselmin, Ulrich Julius, Nadine Weinert, et al.
Free Radical Biology & Medicine|February 28, 2012
Triglyceride, nonesterified fatty acids, and prediabetic neuropathy: role for oxidative-nitrosative stressSergey Lupachyk, Pierre Watcho, Nailia Hasanova, et al.
Atherosclerosis. Supplements|February 5, 2010
The Dresden Apheresis Center - experience with LDL apheresis and immunoadsorptionUlrich Julius, Sergey Tselmin, Sabine Fischer, et al.
Pageof 9